Understanding the Cancer Disparity: More Women Diagnosed, More Men Dying in India

Tue Sep 16 2025 17:24:19 GMT+0300 (Eastern European Summer Time)

A recent study reveals a striking paradox in India's cancer statistics: while women are more likely to be diagnosed with cancer, men face a higher mortality rate. This article delves into the underlying causes and implications of this troubling trend.

In India, the cancer landscape shows a troubling contradiction—women account for over half of new cancer cases, yet men experience significantly higher mortality rates. The disparities stem from differences in early diagnosis, lifestyle factors, and healthcare access. The article explores major cancer types affecting both genders and highlights the urgent need for targeted prevention and public health interventions.

Women in India are more likely to get cancer. Men are more likely to die from it.

The paradox, revealed in a study of the country's latest cancer registry, tells a story at once simple and confounding.

Women account for just over half of all new cases, but men make up the majority of deaths.

India appears to be an outlier. In 2022, for every 100,000 people worldwide, on average about 197 were diagnosed with cancer that year. Men fared worse, at 212, compared to 186 for women, according to the World Cancer Research Fund.

In India, the most common cancers among women are breast, cervical, and ovarian. Rising cases of these hormone-related cancers are associated with lifestyle shifts. For men, oral, lung, and prostate cancers dominate, with tobacco driving the majority of preventable cancers.

Awareness campaigns and improved facilities mean cancers common among women are often detected earlier, resulting in lower mortality rates compared to men. Men's cancers tend to be more aggressive and linked to lifestyle choices, contributing to their higher mortality.

Disparities in cancer burden across India reflect complex social, regional, and lifestyle factors that continue to shape healthcare challenges. The stark difference in incidence and mortality between genders highlights the need for concerted public health efforts aimed at prevention, early diagnosis, and treatment accessibility.